Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling
NCT03795402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2019-12-13
Summary
The purpose of this study is to collect skin biopsies and non-invasive microneedle device samples from participants with mild chronic plaque psoriasis vulgaris to use for transcriptomics profiling for further investigation.
Conditions
- Psoriasis Vulgaris
Interventions
- DEVICE
-
Microneedle Device
Microneedle device will be used for collecting skin samples as a non-invasive method.
Sponsors & Collaborators
-
Innovaderm Research Inc.
collaborator OTHER -
Janssen Research & Development, LLC
lead INDUSTRY
Principal Investigators
-
Janssen Research & Development, LLC Clinical Trial · Janssen Research & Development, LLC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-15
- Primary Completion
- 2019-11-25
- Completion
- 2019-12-06
Countries
- Canada
Study Locations
More Related Trials
-
A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
NCT01700985 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)
NCT06095102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
NCT01504113 ·Status: UNKNOWN
-
A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)
NCT03065556 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis
NCT03706209 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
miRNAs and mRNAs in Psoriasis
NCT01604902 ·Status: UNKNOWN
-
Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis
NCT00539929 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)
NCT04229836 ·Status: COMPLETED ·Phase: PHASE4
-
An Explorative Psoriasis Biomarker Study
NCT04394936 ·Status: TERMINATED ·Phase: NA
-
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
NCT01971346 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis
NCT03759197 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis
NCT03337022 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)
NCT03731052 ·Status: COMPLETED ·Phase: PHASE3
-
Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
NCT00192517 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis
NCT05223868 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis
NCT03358290 ·Status: TERMINATED ·Phase: PHASE2
-
A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
NCT05364554 ·Status: COMPLETED ·Phase: PHASE2
-
A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis
NCT03718299 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis
NCT07314060 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
NCT06095115 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
NCT05357755 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis
NCT02223039 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
NCT01071252 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis
NCT00770965 ·Status: COMPLETED ·Phase: PHASE2